Curiosity Encyclopedia | Investment Dilemma: Leading Stocks in the Cannabis Industry

When you hear the word 'cannabis,' what comes to mind? But do you truly understand cannabis? The Past and Present of Cannabis — 'Half Angel, Half Devil' The cannabis plant contains two natural compounds: tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is a neuroactive substance—and the chief culprit behind cannabis’s classification as a controlled narcotic. In contrast, CBD is non-neuroactive and antagonizes THC, effectively counteracting THC’s effects on the human nervous system; thus, CBD has found applications in medical treatments. Based on THC content, cannabis is divided into industrial hemp and narcotic (recreational) cannabis. In China, industrial hemp is known as 'Han hemp' and boasts wide-ranging applications: hemp fiber can be processed into high-end textiles, while hemp seeds serve as food and animal feed. The editor once spotted a cannabis plant in a remote wilderness area—and nearly dialed 110 in panic… Turns out, it was just a harmless herb… Back home, better munch on some hemp seeds to calm your nerves! Now that we’ve gained a somewhat rudimentary understanding of cannabis, let’s introduce today’s protagonist—the U.S.-listed industrial hemp pioneer Tilray. Company Profile Tilray Inc. is a Canadian pharmaceutical company and cannabis producer headquartered in British Columbia, Canada, incorporated in the United States, and operating in Australia, New Zealand, Germany, and other countries. It engages in the sale and development of medical cannabis. Its product portfolio includes dried cannabis flower and cannabis extracts—such as full-spectrum oils, purified oil tinctures, and capsules. Tilray pioneered the future of global medical cannabis research, cultivation, processing, and distribution, and owns over 3 million square feet of land dedicated to cannabis cultivation. The company aims to become a leader in Canada’s adult-use cannabis market. Moments of Glory Amid Growth — How a 'Meme Stock' Was Forged July 2018: Tilray listed on the NASDAQ; its stock initially performed modestly. August 2018 onward: A string of positive catalysts triggered explosive price growth. September 18, 2018: Three favorable developments occurred simultaneously—most notably, the CEO, during a post-market interview, hinted at imminent collaborations with alcohol and pharmaceutical companies. September 19, 2018: Tilray’s stock experienced extreme volatility—surging up to 93.57% intraday (+$145), briefly touching $300 per share, pushing its market capitalization above $24 billion for the first time—followed by five circuit-breaker-triggered declines. Wall Street issued warnings, cautioning that cannabis stocks might become the next bubble after cryptocurrencies. As of yesterday, July 2, 2019, Tilray closed at $47.39. Current Legalization Status In 1988, the United Nations explicitly stipulated that cannabis plants containing less than 0.3% THC may be utilized industrially. In October 2018, Canada legalized recreational cannabis. To date, 34 countries—including Germany, Australia, Israel, and South Korea—have fully legalized medical cannabis; another nine—including the UK, France, and New Zealand—permit limited, regulated use of medical cannabis. Industrial Hemp Industry Overview After a bumpy, three-steps-forward-two-steps-back path toward legalization, industrial hemp is currently used primarily in fiber-based products and medical applications.

March 5, 2021 (Market Information Recap)

March 5, 2021 (Market Information Recap) Federal Reserve Chair Jerome Powell gave no signal of intervention amid the recent sharp surge in U.S. Treasury yields—prompting yields to spike again during trading hours and accelerating the U.S. equity market’s decline, continuing the tech-stock-led selloff seen earlier. Contrary to market expectations, OPEC+ decided against increasing oil production in April, sending crude oil prices and energy stocks sharply higher. Following Powell’s remarks, the yield on the 10-year Treasury note rose back above 1.5%, climbing 10 basis points from its intraday low. The Dow Jones Industrial Average plunged over 700 points at one point; the Nasdaq Composite fell more than 2%—hitting a two-month low; Tesla slid over 4%; and the semiconductor ETF dropped over 4%. Crude oil surged over 4%, with U.S. crude hitting a near two-year high. The U.S. dollar soared to a four-month peak, while Bitcoin briefly tumbled over $4,000. Gold sank to a near nine-month low; London nickel futures fell over $1,200 for the second consecutive day—hitting a four-month low. U.S. Equity Markets: On Thursday, Eastern Time, all three major U.S. indices closed lower, with the Nasdaq down over 2%. Sector-wise, electric vehicle, semiconductor, and blockchain-related stocks continued their downward trend, while oil stocks rallied again. At market close, the Nasdaq fell 274.28 points to 12,723.47—a 2.11% decline; the Dow Jones Industrial Average dropped 345.95 points to 30,924.14—a 1.11% decline; and the S&P 500 Index declined 51.25 points to 3,768.47—a 1.34% decline. European Equity Markets: On Thursday, European time, major European indices posted mixed results—UK and German markets edged slightly lower. At market close: The FTSE 100 index on the London Stock Exchange stood at 6,650.88—down 24.59 points, or 0.37%, from the previous trading day; Germany’s DAX 30 index closed at 14,056.34—down 23.69 points, or 0.17%; and France’s CAC 40 index ended at 5,830.65—up 0.59 points, or 0.01%.

Oil-Dri Corp of America stock hits all-time high at 106.89 USD

Jul 13, 2026

Oil-Dri Corporation of America stock reached an all-time high of $106.89, driven by strong Q3 fiscal 2026 results showing a 9% rise in net sales and increased dividends.

Investing.com

2026-03-25

Oil Dri declares $0.205 dividend

2026-03-25

Oil-Dri Q1 Earnings Decline Year-Over-Year Amid Tough Comparison Pressures

2026-04-03

Oil-Dri Updates Deferred Compensation Plan and Restricted Stock Agreements

2026-04-03

Oil-Dri Corporation of America Insiders Dispose Stock Amid Bearish Signals

2026-04-04

Oil-Dri Corporation Share Price Crosses Above 200-Day Moving Average